Variants Affecting Exon Skipping Contribute to Complex Traits

English version České info

DNA variants that affect alternative splicing and the relative quantities of different gene transcripts have been shown to be risk alleles for some Mendelian diseases. However, for complex traits characterized by a low odds ratio for any single contributing variant, very few studies have investigated the contribution of splicing variants. The overarching goal of this study is to discover and characterize the role that variants affecting alternative splicing may play in the genetic etiology of complex traits, which include a significant number of the common human diseases. Specifically, we hypothesize that single nucleotide polymorphisms (SNPs) in splicing regulatory elements can be characterized in silico to identify variants affecting splicing, and that these variants may contribute to the etiology of complex diseases as well as the inter-individual variability in the ratios of alternative transcripts. We leverage high-throughput expression profiling to 1) experimentally validate our in silico predictions of skipped exons and 2) characterize the molecular role of intronic genetic variations in alternative splicing events in the context of complex human traits and diseases. We propose that intronic SNPs play a role as genetic regulators within splicing regulatory elements and show that their associated exon skipping events can affect protein domains and structure. We find that SNPs we would predict to affect exon skipping are enriched among the set of SNPs reported to be associated with complex human traits.

Vyšlo v časopise: Variants Affecting Exon Skipping Contribute to Complex Traits. PLoS Genet 8(10): e32767. doi:10.1371/journal.pgen.1002998
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002998

Souhrn

Zdroje

1. JohnsonJM, CastleJ, Garrett-EngeleP, KanZ, LoerchPM, et al. (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302: 2141–2144.

2. WangET, SandbergR, LuoS, KhrebtukovaI, ZhangL, et al. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470–476.

3. PanQ, ShaiO, LeeLJ, FreyBJ, BlencoweBJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nature genetics 40: 1413–1415.

4. GraveleyBR, BrooksAN, CarlsonJW, DuffMO, LandolinJM, et al. (2011) The developmental transcriptome of Drosophila melanogaster. Nature 471: 473–479.

5. GabutM, Samavarchi-TehraniP, WangX, SlobodeniucV, O'HanlonD, et al. (2011) An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 147: 132–146.

6. PolymenidouM, Lagier-TourenneC, HuttKR, HuelgaSC, MoranJ, et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nature neuroscience 14: 459–468.

7. VenablesJP, KlinckR, KohC, Gervais-BirdJ, BramardA, et al. (2009) Cancer-associated regulation of alternative splicing. Nature structural & molecular biology 16: 670–676.

8. BarashY, CalarcoJA, GaoW, PanQ, WangX, et al. (2010) Deciphering the splicing code. Nature 465: 53–59.

9. GaildratP, KriegerS, TheryJC, KillianA, RousselinA, et al. (2010) The BRCA1 c.5434C→G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements. Journal of medical genetics 47: 398–403.

10. VenablesJP (2004) Aberrant and alternative splicing in cancer. Cancer research 64: 7647–7654.

11. LefaveCV, SquatritoM, VorlovaS, RoccoGL, BrennanCW, et al. (2011) Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. The EMBO journal 30: 4084–4097.

12. ShapiroIM, ChengAW, FlytzanisNC, BalsamoM, CondeelisJS, et al. (2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218 doi:10.1371/journal.pgen.1002218

13. Allende-VegaN, DayalS, AgarwalaU, SparksA, BourdonJC, et al. (2012) p53 is activated in response to disruption of the pre-mRNA splicing machinery. Oncogene

14. YuY, MaroneyPA, DenkerJA, ZhangXH, DybkovO, et al. (2008) Dynamic regulation of alternative splicing by silencers that modulate 5′ splice site competition. Cell 135: 1224–1236.

15. HeinzenEL, GeD, CroninKD, MaiaJM, ShiannaKV, et al. (2008) Tissue-specific genetic control of splicing: implications for the study of complex traits. PLoS Biol 6: e1000001 doi:10.1371/journal.pbio.1000001

16. YinH, LuQ, WoodM (2008) Effective exon skipping and restoration of dystrophin expression by peptide nucleic acid antisense oligonucleotides in mdx mice. Mol Ther 16: 38–45.

17. MitrpantC, AdamsAM, MeloniPL, MuntoniF, FletcherS, et al. (2009) Rational design of antisense oligomers to induce dystrophin exon skipping. Mol Ther 17: 1418–1426.

18. van DeutekomJC, JansonAA, GinjaarIB, FrankhuizenWS, Aartsma-RusA, et al. (2007) Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357: 2677–2686.

19. MedinaMW, KraussRM (2009) The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc Med 19: 173–177.

20. DiFeoA, FeldL, RodriguezE, WangC, BeerDG, et al. (2008) A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res 68: 965–970.

21. NarlaG, DifeoA, ReevesHL, SchaidDJ, HirshfeldJ, et al. (2005) A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Res 65: 1213–1222.

22. CaceresJF, KornblihttAR (2002) Alternative splicing: multiple control mechanisms and involvement in human disease. Trends in genetics : TIG 18: 186–193.

23. CartegniL, ChewSL, KrainerAR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285–298.

24. FaustinoNA, CooperTA (2003) Pre-mRNA splicing and human disease. Genes & development 17: 419–437.

25. PaganiF, BaralleFE (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nature reviews Genetics 5: 389–396.

26. Sterne-WeilerT, HowardJ, MortM, CooperDN, SanfordJR (2011) Loss of exon identity is a common mechanism of human inherited disease. Genome research 21: 1563–1571.

27. KwanT, BenovoyD, DiasC, GurdS, ProvencherC, et al. (2008) Genome-wide analysis of transcript isoform variation in humans. Nat Genet 40: 225–231.

28. PickrellJK, MarioniJC, PaiAA, DegnerJF, EngelhardtBE, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature 464: 768–772.

29. CirulliET, SinghA, ShiannaKV, GeD, SmithJP, et al. (2010) Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol 11: R57.

30. DuanS, HuangRS, ZhangW, BleibelWK, RoeCA, et al. (2008) Genetic architecture of transcript-level variation in humans. American journal of human genetics 82: 1101–1113.

31. HindorffLA, SethupathyP, JunkinsHA, RamosEM, MehtaJP, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106: 9362–9367.

32. YeoG, HoonS, VenkateshB, BurgeCB (2004) Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc Natl Acad Sci U S A 101: 15700–15705.

33. GamazonER, ZhangW, KonkashbaevA, DuanS, KistnerEO, et al. (2010) SCAN: SNP and copy number annotation. Bioinformatics 26: 259–262.

34. BowcockAM, KruegerJG (2005) Getting under the skin: the immunogenetics of psoriasis. Nature reviews Immunology 5: 699–711.

35. Lango AllenH, EstradaK, LettreG, BerndtSI, WeedonMN, et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832–838.

36. BishopDT, DemenaisF, IlesMM, HarlandM, TaylorJC, et al. (2009) Genome-wide association study identifies three loci associated with melanoma risk. Nature genetics 41: 920–925.

37. FlicekP, AmodeMR, BarrellD, BealK, BrentS, et al. (2011) Ensembl 2011. Nucleic acids research 39: D800–806.

38. GraveleyBR (2009) Alternative splicing: regulation without regulators. Nat Struct Mol Biol 16: 13–15.

39. BaraniakAP, ChenJR, Garcia-BlancoMA (2006) Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice. Molecular and cellular biology 26: 1209–1222.

40. FagnaniM, BarashY, IpJY, MisquittaC, PanQ, et al. (2007) Functional coordination of alternative splicing in the mammalian central nervous system. Genome biology 8: R108.

41. HuhGS, HynesRO (1994) Regulation of alternative pre-mRNA splicing by a novel repeated hexanucleotide element. Genes & development 8: 1561–1574.

42. JinY, SuzukiH, MaegawaS, EndoH, SuganoS, et al. (2003) A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. The EMBO journal 22: 905–912.

43. LimLP, SharpPA (1998) Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Molecular and cellular biology 18: 3900–3906.

44. MinovitskyS, GeeSL, SchokrpurS, DubchakI, ConboyJG (2005) The splicing regulatory element, UGCAUG, is phylogenetically and spatially conserved in introns that flank tissue-specific alternative exons. Nucleic acids research 33: 714–724.

45. PonthierJL, SchluepenC, ChenW, LerschRA, GeeSL, et al. (2006) Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. The Journal of biological chemistry 281: 12468–12474.

46. UnderwoodJG, BoutzPL, DoughertyJD, StoilovP, BlackDL (2005) Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Molecular and cellular biology 25: 10005–10016.

47. ZhangW, LiuH, HanK, GrabowskiPJ (2002) Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR. RNA 8: 671–685.

48. ZhuH, HasmanRA, YoungKM, KedershaNL, LouH (2003) U1 snRNP-dependent function of TIAR in the regulation of alternative RNA processing of the human calcitonin/CGRP pre-mRNA. Molecular and cellular biology 23: 5959–5971.

49. GenettaT, MorisakiH, MorisakiT, HolmesEW (2001) A novel bipartite intronic splicing enhancer promotes the inclusion of a mini-exon in the AMP deaminase 1 gene. The Journal of biological chemistry 276: 25589–25597.

50. GuoN, KawamotoS (2000) An intronic downstream enhancer promotes 3′ splice site usage of a neural cell-specific exon. The Journal of biological chemistry 2000/08/10 ed 33641–33649.

51. LiuS, AltmanRB (2003) Large scale study of protein domain distribution in the context of alternative splicing. Nucleic acids research 31: 4828–4835.

52. LewisBP, GreenRE, BrennerSE (2003) Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proceedings of the National Academy of Sciences of the United States of America 100: 189–192.

53. AlekseyenkoAV, KimN, LeeCJ (2007) Global analysis of exon creation versus loss and the role of alternative splicing in 17 vertebrate genomes. RNA 13: 661–670.

54. SugnetCW, KentWJ, AresMJr, HausslerD (2004) Transcriptome and genome conservation of alternative splicing events in humans and mice. Pacific Symposium on Biocomputing Pacific Symposium on Biocomputing 66–77.

55. HaK, Coulombe-HuntingtonJ, MajewskiJ (2009) Comparison of Affymetrix Gene Array with the Exon Array shows potential application for detection of transcript isoform variation. BMC genomics 10: 519.

56. NicaAC, PartsL, GlassD, NisbetJ, BarrettA, et al. (2011) The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet 7: e1002003 doi:10.1371/journal.pgen.1002003

57. FujitaPA, RheadB, ZweigAS, HinrichsAS, KarolchikD, et al. The UCSC Genome Browser database: update 2011. Nucleic acids research 39: D876–882.

58. KuhnRM, KarolchikD, ZweigAS, WangT, SmithKE, et al. (2009) The UCSC Genome Browser Database: update 2009. Nucleic acids research 37: D755–761.

59. BensonDA, Karsch-MizrachiI, LipmanDJ, OstellJ, WheelerDL (2004) GenBank: update. Nucleic acids research 32: D23–26.

60. HubbardT, BarkerD, BirneyE, CameronG, ChenY, et al. (2002) The Ensembl genome database project. Nucleic acids research 30: 38–41.

61. Thierry-MiegD, Thierry-MiegJ (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1 S12 11–14.

62. HsuF, KentWJ, ClawsonH, KuhnRM, DiekhansM, et al. (2006) The UCSC Known Genes. Bioinformatics 22: 1036–1046.

63. KentWJ (2002) BLAT–the BLAST-like alignment tool. Genome Res 12: 656–664.

64. ZhangW, DuanS, BleibelWK, WiselSA, HuangRS, et al. (2009) Identification of common genetic variants that account for transcript isoform variation between human populations. Human genetics 125: 81–93.

65. IncA (2006) Identifying and validating alternative splicing events. Affymetrix Technical Note

66. NicolaeDL, GamazonE, ZhangW, DuanS, DolanME, et al. (2010) Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet 6: e1000888 doi:10.1371/journal.pgen.1000888

67. StoreyJD, TibshiraniR (2003) Statistical significance for genomewide studies. Proceedings of the National Academy of Sciences of the United States of America 100: 9440–9445.

68. RoyA, KucukuralA, ZhangY (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nature protocols 5: 725–738.

69. ZhangY, SkolnickJ (2005) TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic acids research 33: 2302–2309.